Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Capital/Financing Update 2024

Oct 18, 2024

3535_rns_2024-10-18_86652678-e9b9-4e8e-bd8c-b6dd4b559f72.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Aqua Bio Technology ASA – Key information relating to the Subsequent Offering

18.10.2024 08:52:59 CEST | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state

Reference is made to the announcement by Aqua Bio Technology ASA on 18 October 2024 concerning the successful placement of the conditional private placement with total gross proceeds of approximately NOK 115 million, and a contemplated subsequent offering (the "Subsequent Offering").

Key information for the Subsequent Offering is set out below:

Date on which the terms of the Subsequent 17 October 2024
Offering was announced:
Last day including right: 17 October 2024
First day excluding right: 18 October 2024
Record date: 21 October 2024
EGM date: On or about 12 November 2024 (to be summoned)
Maximum number of new shares: 2,000,000
Subscription price: NOK 3.00
Shall the rights be listed No

The issuance of new shares in the Subsequent Offering will be subject to approval of the pertaining share capital increase by the EGM to be held on or about 12 November 2024. The Subsequent Offering is expected to be carried out during the notice period for the EGM, with a one-week subscription period, expected to expire at least three days prior to the date of the EGM.

This information is published in accordance with the requirements of the Continuing Obligations in Euronext Rule Book II.

Disclosure regulation

This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.

Contacts

Jan Aas Varming, CFO, Aqua Bio Technology ASA, +47 908 39 076, [email protected]

About Aqua Bio Technology ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. Aqua Bio Technology is listed on Euronext Expand.

Attachments

Download announcement as PDF.pdf